Lecanemab Gains FDA Approval for Early Alzheimer Disease
Howard D. Larkin
The abstract is not reproduced here because its license does not permit redistribution. Read it at the original source.
Record
- Archive ID
- doi:10.1001/jama.2022.24490
- Published
- Jan 18, 2023
- Venue
- JAMA
- DOI
- 10.1001/jama.2022.24490
- PubMed
- 36652625
- Categories
- Alzheimer's disease research and treatments
- Provenance
- openalex